Omada Health raises margin targets; Barclays lifts price target
Omada Health raised long-term targets, including gross margin to 80% and adjusted EBITDA margin to 30%. Barclays maintained an Overweight rating and lifted its price target to $27.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.